Pharmacologic relevance of K(+)Channel remodeling in atrial fibrillation.
Van Wagoner
D R
DR
D000200:Action Potentials; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000378:metabolism*; D004594:Electrophysiology; D005260:Female; D006801:Humans; D007477:Ions; D010641:Phenotype; D015221:Potassium Channels / Q000502:physiology*
D000889:Anti-Arrhythmia Agents; D007477:Ions; D015221:Potassium Channels